CTLA4 and neoplasm: In addition, the results show that AU-011 combined with anti-CTLA-4, PD-L1 and LAG-3 with PD-L1, but not LAG-3 alone, is more effective in reducing the total tumor burden and enhancing the survival of animals bearing bilateral tumors than either treatment alone.